BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 15156445)

  • 41. Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.
    File TM; Garau J; Jacobs MR; Wynne B; Twynholm M; Berkowitz E
    Int J Antimicrob Agents; 2005 Feb; 25(2):110-9. PubMed ID: 15664480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci.
    Pallares R; Gudiol F; Liñares J; Ariza J; Rufi G; Murgui L; Dorca J; Viladrich PF
    N Engl J Med; 1987 Jul; 317(1):18-22. PubMed ID: 3587309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes.
    Garcia-Vidal C; Ardanuy C; Tubau F; Viasus D; Dorca J; Liñares J; Gudiol F; Carratalà J
    Thorax; 2010 Jan; 65(1):77-81. PubMed ID: 19996337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.
    Friedland IR; McCracken GH
    N Engl J Med; 1994 Aug; 331(6):377-82. PubMed ID: 8028618
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens.
    Song JH; Oh WS; Kang CI; Chung DR; Peck KR; Ko KS; Yeom JS; Kim CK; Kim SW; Chang HH; Kim YS; Jung SI; Tong Z; Wang Q; Huang SG; Liu JW; Lalitha MK; Tan BH; Van PH; Carlos CC; So T;
    Int J Antimicrob Agents; 2008 Feb; 31(2):107-14. PubMed ID: 18162378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiology of invasive pneumococcal disease in Kumasi, Ghana.
    Holliman RE; Liddy H; Johnson JD; Adjei O
    Trans R Soc Trop Med Hyg; 2007 Apr; 101(4):405-13. PubMed ID: 17126867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
    Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H
    Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia.
    Jones RN; Jacobs MR; Sader HS
    Int J Antimicrob Agents; 2010 Sep; 36(3):197-204. PubMed ID: 20558045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hospital-acquired pneumococcal bacteremia.
    Canet JJ; Juan N; Xercavins M; Freixas N; Garau J
    Clin Infect Dis; 2002 Sep; 35(6):697-702. PubMed ID: 12203167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia.
    Naucler P; Darenberg J; Morfeldt E; Ortqvist A; Henriques Normark B
    Thorax; 2013 Jun; 68(6):571-9. PubMed ID: 23442364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.
    Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Utility of blood cultures on antibiotic therapy in adult bacteremic pneumococcal pneumonia].
    Mathurin L S; Agüero L A; Jaimet A C; Schälibaum G E; Demergasso S M; Acuña S V
    Rev Chilena Infectol; 2009 Feb; 26(1):9-17. PubMed ID: 19350153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-level penicillin-nonsusceptible Streptococcus pneumoniae bacteremia: identification of a low-risk subgroup.
    Ruhe JJ; Myers L; Mushatt D; Hasbun R
    Clin Infect Dis; 2004 Feb; 38(4):508-14. PubMed ID: 14765343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Invasive pneumococcal disease in Kanti Children's Hospital, Nepal, as observed by the South Asian Pneumococcal Alliance network.
    Shah AS; Knoll MD; Sharma PR; Moisi JC; Kulkarni P; Lalitha MK; Steinhoff M; Thomas K
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S123-8. PubMed ID: 19191607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of comorbidity and severity on the clinical outcome of bacteremic pneumococcal pneumonia treated with beta-lactam monotherapy.
    Garau J; Aguilar L; Rodríguez-Créixems M; Dal-ré R; Pérez-Trallero E; Rodríguez M; Bouza E
    J Chemother; 1999 Aug; 11(4):266-72. PubMed ID: 10465128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased?
    Vallès X; Marcos A; Pinart M; Piñer R; Marco F; Mensa JM; Torres A
    Chest; 2006 Sep; 130(3):800-6. PubMed ID: 16963678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial susceptibilities and analysis of genes related to penicillin or macrolide resistance in Streptococcus pneumoniae.
    Hiramatsu K; Ohama M; Mijajima Y; Kishi K; Mizunoe S; Tokimatsu I; Nagai H; Kadota J; Saikawa T; Nasu M
    Int J Antimicrob Agents; 2004 Aug; 24(2):125-9. PubMed ID: 15288310
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Invasive pneumococcal disease in children aged <5 years admitted to 3 urban hospitals in Ibadan, Nigeria.
    Falade AG; Lagunju IA; Bakare RA; Odekanmi AA; Adegbola RA
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S190-6. PubMed ID: 19191615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents.
    Pottumarthy S; Fritsche TR; Sader HS; Stilwell MG; Jones RN
    Int J Antimicrob Agents; 2005 Apr; 25(4):282-9. PubMed ID: 15784306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.